Gender difference and characteristics attributed to coronary artery disease in Gaza-Palestine

Amal Jamee1, Yehia Abed, Marwan O Jalambo

  • 1Foods and chemicals Products Laboratories, Ministry of National Economy. moj_biology@yahoo.com.

Insights

Coronary artery disease (CAD) affects both men and women, though risk factors and presentation differ. This study analyzed cardiovascular risk factors to understand gender disparities in CAD, finding certain patient characteristics place females at higher risk.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Coronary artery disease (CAD) historically underrepresented women in research.
  • Cardiovascular disease risk escalates with age in both sexes.
  • Identified modifiable and non-modifiable risk factors influence CAD development.

Purpose of the Study:

  • To investigate the extent to which cardiovascular risk factors explain gender differences in CAD.
  • To analyze gender-specific patterns in CAD risk factors and clinical presentation.
  • To highlight emerging knowledge on gender disparities in CAD risk and intervention response.

Main Methods:

  • Cross-sectional study of 155 cardiac patients at Al-shifa Hospital, Gaza.
  • Data collected on smoking, diabetes, hypertension, dyslipidemia, and family history.
  • Statistical analysis included frequency, cross-tabulation, and Chi-square tests (P<0.05 significance).

Main Results:

  • Females generally exhibited more favorable risk factor profiles but higher rates of chronic angina.
  • Males experienced myocardial infarction twice as often as females.
  • Approximately 77% of females had two or more diseased vessels; low ejection fraction (<50%) correlated with more affected vessels.

Conclusions:

  • CAD remains a significant issue for both genders.
  • Specific patient characteristics and clinical conditions may increase female risk for CAD development or progression.
  • Understanding gender differences in CAD risk factors and intervention response is crucial.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...